Marina M Scotti,
Biological Scientist III
Department:
Molecular Genetics & Microbiology
Business Phone:
(352) 273-9236
Business Email:
because@ufl.edu
Publications
Academic Articles
2024
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1.
Molecular therapy. Nucleic acids.
35(4)
[DOI] 10.1016/j.omtn.2024.102338.
[PMID] 39391766.
2024
Spaceflight effects on human vascular smooth muscle cell phenotype and function.
NPJ microgravity.
10(1)
[DOI] 10.1038/s41526-024-00380-w.
[PMID] 38548798.
2024
Therapeutic targeting of RNA for neurological and neuromuscular disease.
Genes & development.
38(15-16):698-717
[DOI] 10.1101/gad.351612.124.
[PMID] 39142832.
2021
Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice.
Human molecular genetics.
29(24):3900-3918
[DOI] 10.1093/hmg/ddaa279.
[PMID] 33378537.
2020
HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
Proceedings of the National Academy of Sciences of the United States of America.
117(10):5472-5477
[DOI] 10.1073/pnas.1907297117.
[PMID] 32086392.
2020
Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood.
Nature communications.
11(1)
[DOI] 10.1038/s41467-020-15962-x.
[PMID] 32332745.
2017
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
Genes & development.
31(11):1122-1133
[DOI] 10.1101/gad.300590.117.
[PMID] 28698297.
2016
RNA mis-splicing in disease.
Nature reviews. Genetics.
17(1):19-32
[DOI] 10.1038/nrg.2015.3.
[PMID] 26593421.
2014
Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector.
Human gene therapy. Clinical development.
25(4):212-7
[DOI] 10.1089/humc.2014.060.
[PMID] 25357151.
2012
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy.
Neuron.
75(3):437-50
[DOI] 10.1016/j.neuron.2012.05.029.
[PMID] 22884328.
2011
Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system.
Gene therapy.
18(2):135-44
[DOI] 10.1038/gt.2010.102.
[PMID] 20668485.
2009
An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
Gene therapy.
16(2):229-39
[DOI] 10.1038/gt.2008.158.
[PMID] 18923452.
2009
Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells.
Human gene therapy.
20(8):861-70
[DOI] 10.1089/hum.2009.004.
[PMID] 19419276.
Contact Details
Phones:
- Business:
- (352) 273-9236
Emails:
- Business:
- because@ufl.edu
Addresses:
- Business Mailing:
-
PO BOX 103610
GAINESVILLE FL 326116400 - Business Street:
-
2033 MOWRY RD RM 215
GAINESVILLE FL 32610